Hamps Bio Limited, established in 2007 and headquartered in Ankleshwar, Gujarat, is rapidly making a name for itself in the pharmaceutical and freeze-dried food industries. The company recently launched its IPO on December 13, 2024, aiming to raise ₹6.22 crores by issuing 12.2 lakh equity shares at ₹51 per share. With its commitment to quality, sustainability, and rural employment, Hamps Bio Limited is well-positioned for significant growth both in India and internationally. The company’s products range from pharmaceutical formulations to freeze-dried foods under the popular FzyEzy brand.
What is Hamps Bio Limited?
Hamps Bio Limited is a leading pharmaceutical and FMCG company, focusing on both the pharmaceutical sector and the freeze-dried food market. Hamps Bio Limited, also known as Hamps Bio Pvt Ltd Ankleshwar, operates out of Gujarat and has made impressive strides in the industry. With a growing portfolio of over 180 pharmaceutical products, including tablets, syrups, and injectables, along with its freeze-dried foods under FzyEzy, Hamps Bio Limited has created a strong footprint in both healthcare and nutrition sectors.
Understanding Hamps Bio DRHP – What Investors Need to Know
The Hamps Bio DRHP (Draft Red Herring Prospectus) is a crucial document for investors interested in the Hamps Bio IPO. The Hamps Bio DRHP details the company’s financials, operations, and future plans, helping potential investors understand where their money will be going. The Hamps Bio DRHP also outlines the objective of raising ₹6.22 crores to enhance production capabilities, increase brand visibility, and cover general corporate purposes. The Hamps Bio IPO is a big step towards achieving these goals.
Key Details of the Hamps Bio IPO
The Hamps Bio IPO opened on December 13, 2024, and is expected to close on December 17, 2024. The Hamps Bio IPO offers 12.2 lakh equity shares at a price of ₹51 per share, raising a total of ₹6.22 crores. The Hamps Bio IPO is designed to boost the company’s production capacity, increase brand visibility, and fund general corporate purposes. With a minimum investment of ₹1,02,000 (which includes 2,000 shares), the Hamps Bio IPO presents a great investment opportunity for retail investors.
Why Hamps Bio Limited is a Strong Investment Choice
With the Hamps Bio IPO GMP (Grey Market Premium) showing strong investor interest, Hamps Bio Limited stands out as a promising investment. The company’s diverse portfolio, which includes over 100 pharmaceutical products and freeze-dried products under the FzyEzy brand, makes it an attractive option for those looking to invest in both the pharmaceutical and FMCG sectors. The company’s commitment to sustainability and rural employment generation further enhances its long-term growth potential.
Hamps Bio Products: A Look at Their Diverse Range
Hamps Bio Products include a wide variety of medicinal formulations, as well as freeze-dried fruits, vegetables, and herbs marketed under the FzyEzy brand. These products are designed to cater to the growing demand for health-conscious and sustainable food choices. Hamps Bio Limited has expanded its offerings to nutrition bars, ice cream, and other products, making Hamps Bio Products a major player in the freeze-dried food market.
The Market Reach and Expansion of Hamps Bio Limited
With a strong market presence, Hamps Bio Limited has made significant strides in both domestic and international markets. The company’s robust sales network reaches over 8,000 doctors and medical stores every month across eight Indian states and six countries. The growing popularity of Hamps Products and the company’s expanding online presence on platforms like Amazon and Flipkart further amplify its growth prospects.
Who Are the Hamps Owners?
Hamps Bio Limited is promoted by Herrik Shah, Shrenik Shah, Pallavi Shah, and Mitali Shah, along with their respective Hindu Undivided Families (HUFs). These Hamps owners were responsible for the initial establishment and growth of Hamps Bio Limited. After the IPO, the Hamps owners will see their combined ownership reduce to approximately 72%. Their continued involvement in the company ensures strong leadership and stability as Hamps Bio Limited continues to expand.
The Meaning of Hamps
The term Hamps in Hamps Bio Limited symbolizes the company’s values and its focus on providing high-quality products. Hamps Bio Limited operates with a mission to provide both pharmaceuticals and nutritious foods, combining these elements to create a brand that supports sustainability and health-consciousness. The name Hamps reflects the company’s goal of promoting wellness and eco-friendly practices across all its operations.
Why Invest in Hamps Bio Limited?
Investing in Hamps Bio Limited offers a promising opportunity for those looking to tap into the growth potential of both the pharmaceutical and FMCG sectors. The company’s expansion plans and its focus on sustainable development make it an attractive choice for investors. With strong products, a growing market presence, and a solid leadership team, Hamps Bio Limited is set to achieve long-term success.
Create Your Demat Account and Start Investing in Hamps Bio Limited
If you’re interested in investing in Hamps Bio Limited or any other stock, it’s essential to have a Demat account. Click the button below to create your Demat account with GRM Bulls:
Create a Demat Account with GRM Bulls
At GRM Bulls, we offer expert financial services and assistance to help you achieve your investment goals. If you want to learn how to analyze stocks and make smarter investments, visit our website at GRM IIT. We are experts in teaching you how to analyze the market and make better decisions, so you avoid losses and maximize your returns.
You can start learning for free on our YouTube channel: GRM IIT YouTube Channel, but for more in-depth paid courses, head to our website for detailed programs and professional guidance.
At GRM IIT, we provide high-quality training in stock market analysis, financial planning, and trading strategies. Without the right knowledge, it’s easy to make mistakes that could lead to losses. Don’t risk it—learn from the experts at GRM IIT and maximize your potential in the financial markets!
Frequently Asked Questions (FAQ) About Hamps Bio IPO
The price range for the Hamps Bio IPO is ₹51 per share. The company aims to raise ₹6.22 crores by issuing 12.2 lakh equity shares.
The Hamps Bio IPO will open on December 13, 2024, and close on December 17, 2024.
The primary objective of the Hamps Bio IPO is to enhance production capacity, increase brand visibility, and cover general corporate purposes.
The promoters of Hamps Bio Limited are Herrik Shah, Shrenik Shah, Pallavi Shah, and Mitali Shah, along with their respective Hindu Undivided Families (HUFs).
Hamps Bio Limited offers pharmaceutical products like tablets, syrups, and injectables, along with freeze-dried food products under the FzyEzy brand, including fruits, vegetables, herbs, and nutrition bars.
To invest in the Hamps Bio IPO, you need to have a Demat account. You can create one through brokers like GRM Bulls for a seamless investment process.